Adjuvant Immune Checkpoint Inhibition in Muscle-invasive Bladder Cancer: Is It Ready for Prime Time?
Author:
Publisher
Elsevier BV
Subject
Urology
Reference12 articles.
1. Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma;Bajorin;N Engl J Med,2021
2. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicenter, open-label, randomized, phase 3 trial;Bellmunt;Lancet Oncol,2021
3. Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer;Sonpavde;J Urol,2011
4. LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361;Alva;Ann Oncol.,2020
5. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicenter, randomized, placebo-controlled phase 3 trial;Galsky;Lancet,2020
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer;Current Cancer Drug Targets;2024-07
2. Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer;Nature Reviews Urology;2023-12-19
3. Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection;European Urology;2023-11
4. Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer;iScience;2023-10
5. Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour‐specific immunity;Clinical and Translational Medicine;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3